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Abstract
Rationale—Sputum and bronchoalveolar lavage fluid (BALF) are often obtained to elucidate the 
lower airway microbiota in adults. Acquiring sputum samples from children is difficult and 
obtaining samples via bronchoscopy in children proves challenging due to the need for anesthesia 
and specialized procedural expertise; therefore nasopharyngeal (NP) swabs are often used as 
surrogates when investigating the pediatric airway microbiota. In adults, the airway microbiota 
differs significantly between NP and BALF samples however, minimal data exist in children.
Objectives—To compare NP and BALF samples in children undergoing clinically indicated 
bronchoscopy.
Methods—NP and BALF samples were collected during clinically indicated bronchoscopy. 
Bacterial DNA was extracted from 72 samples (36 NP/BALF pairs); the bacterial V1-V3 region of 
the 16S rRNA gene was amplified and sequenced on the Illumina Miseq platform. Analysis was 
performed using mothur software.
Results—Compared to NP samples, BALF had increased richness and diversity. Similarity 
between paired NP and BALF (intra-subject) samples was greater than inter-subject samples 
(p=0.0006). NP samples contained more Actinobacteria (2.2% vs. 21%; adjusted p = 1.4 × 10−6), 
while BALF contained more Bacteroidetes (29.5% vs. 3.2%; adjusted p = 1.2 × 10−9). At the 
genus level several differences existed, however Streptococcus abundance was similar in both 
sample types (NP 37.3% vs. BAL 36.1%; adjusted p = 0.8).
Conclusion—Our results provide evidence that NP samples can be used to distinguish 
differences between children, but the relative abundance of organisms may differ between the 
nasopharynx and lower airway in pediatric patients. Studies utilizing NP samples as surrogates for 
the lower airway should be interpreted with caution.
Corresponding author: Kirsten M. Kloepfer MD, MS, 705 Riley Hospital Drive, RI 2606, Indianapolis, IN 46202, Telephone number 
(317) 944-7231, Fax number (317) 278-7856, and kloepfer@iu.edu.
Concept and design: KMK, SDD; Analysis and interpretation: KMK, ARD, SER, SLPC, CMH, DBR; Drafting of manuscript for 
important intellectual content: KMK, SDD
Author Disclaimers: none
HHS Public Access
Author manuscript
Pediatr Pulmonol. Author manuscript; available in PMC 2019 May 30.
Published in final edited form as:
Pediatr Pulmonol. 2018 April ; 53(4): 475–482. doi:10.1002/ppul.23953.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Keywords
microbiota; pediatric; bronchoalveolar lavage fluid; nasopharyngeal swabs
INTRODUCTION
Bronchoscopy with bronchoalveolar lavage fluid (BALF) samples is a common method of 
evaluating the lower airway in children who cannot expectorate. However, performing 
bronchoscopy proves challenging due to the need for anesthesia and specialized procedural 
expertise. Due to ethical concerns, BALF can only be collected from pediatric patients if the 
procedure is clinically indicated; thereby, prohibiting the collection of lower airway samples 
in both healthy children and those with lower respiratory disease unless ordered for clinical 
purposes. Given this, upper airway samples often serve as a surrogate of the lower airway.
In healthy adults, differences exist between the upper and lower airway microbiota1,2. 
Overlap exists between the oral and lung microbiota while the nasal microbiota does not 
share bacterial communities with either location in healthy adults2. Differences between 
sampling location also exist in children and adults with cystic fibrosis3,4. However, there are 
limited studies comparing the upper and lower airway in children without cystic fibrosis.
It was recently reported that upper airway sampling provided a reliable representation of 
BALF microbiota in children with protracted bronchial bronchitis and chronic suppurative 
lung disease with a combination of nasopharyngeal (NP) and oropharyngeal (OP) samples 
offering the best representation of the lower airway5. Because many studies examining upper 
airway diseases including early wheeze have focused on the NP microbiota, we focused on 
comparing the NP microbiota and BALF microbiota in all children regardless of the reason 
for their bronchoscopy. We hypothesized that the NP microbiota and BALF microbiota 
would differ in children regardless of their diagnosis. To address this issue, we compared NP 
swabs and BALF samples from all children undergoing clinically indicated bronchoscopy to 
determine if NP swabs reflect the BALF microbiota.
METHODS
Participants
Inclusion criteria were children undergoing a clinically indicated bronchoscopy in the Riley 
Children’s Hospital outpatient center (Indianapolis, IN). Children were excluded if parents 
and/or children refused to give informed consent. This study was approved by the Indiana 
University Human Subjects Committee. If the participant was <18 years of age, written 
informed consent was obtained from the parents and assent was obtained from children ≥11 
years of age. If the patient was ≥18 years of age, full consent was obtained from the patient. 
After consent was obtained, a questionnaire was administered asking basic demographic 
questions (gender, race, and ethnicity).
NP swabs were obtained prior to bronchoscopy using Copan eSwab 482C in Amies 
Transport Medium (Copan Diagnostics, Murrieta, CA). Samples were obtained by rubbing 
the swab on the mid-inferior turbinate for 10 seconds, then placed in transport media (Amies 
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fluid). Samples were then placed on ice while awaiting BALF collection. Bronchoscopy was 
performed under general anesthesia following current American Thoracic Society (ATS) 
guidelines6. The bronchoscope was introduced via laryngeal mask airway (LMA) or trans-
nasally. Passage of the bronchoscope nasally was utilized when the clinician elected to 
evaluate the upper airway. If bronchoalveolar lavage was performed, any extra BALF 
available that exceeded the 10 mL of BALF necessary for clinically indicated studies was 
collected for this study. BALF was placed in a sterile container, placed on ice with the 
corresponding NP swab, and taken to the laboratory (within the same building) where it was 
aliquoted and stored at −80° C until DNA extraction occurred. An average of 13 mL of 
BALF was collected during the procedure. After removing 10mL for clinically indicated 
laboratory studies, there was an average of 3 mL remaining for this study.
DNA Extraction
Prior to extraction, 1mL of BALF was centrifuged at 10,000 x g for 10 minutes. The pellet 
was re-suspended in 200μL of phosphate buffered saline (PBS, GE HyClone). DNA was 
extracted from NP swabs and BALF using the Qiagen DNeasy Blood and Tissue Kit. A 
DNA library was constructed using primers that amplify the V1–V3 region of the 16S rRNA 
gene. 7,87,87,87,87,8DNA was amplified using Phusion® High-Fidelity DNA Polymerase 
mixture (Thermo Scientific). The PCR protocol was 1 cycle of 30 seconds at 98° C followed 
by 34 cycles of 98° C for 10 seconds, 62° C for 30 seconds, 72° C for 30 seconds and a final 
elongation at 72° C for 5 minutes. The resulting amplicons were purified with QIAquick® 
PCR Purification Kit (Qiagen).
Sequencing was performed on an Illumina MiSeq8. The resulting sequence reads were de-
multiplexed using CASAVA software installed on the MiSeq Illumina sequencer producing 
6,042,668 sequencing reads. Separate pairs of fastq files were generated for each specimen. 
The splicing of forward and reverse fastq files produced an average of 100,710 ± 48,567 
reads per specimen.
Sequence Quality Analysis
16S rRNA sequence processing was performed utilizing mothur (v.1.33.3) software9,10 and 
adapted from their 16S MiSeq Protocol. Raw paired-end fastq sequences were combined 
into contigs using make.contigs. Contigs were then aligned against release 123 of the SILVA 
16S reference alignment using align.seqs, and contigs that did not match the V1-V3 regions 
were discarded. Sequencing error correction was performed with pre.cluster, allowing up to 
three bases to be corrected per read. We then used the UCHIME algorithm11 from within 
mothur to detect and remove chimeric sequences. The classify.seqs command and RDP 
training set were used to filter sequences identified as non-bacteria12.
Operational Taxonomic Unit (OTU) clustering and classification
Remaining sequences were clustered using swarm with the fastidious parameter13,14. Swarm 
is a single-linkage clustering tool that uses a local (rather than global) clustering threshold. 
Sequence abundance is used to delineate OTUs with high precision. The representative 
sequences for each OTU was classified using BLAST 15 against release 123 of the SILVA 
SSU database16. We applied an abundance filter, removing all OTUs that did not compose 
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2% or more of the read population of at least one sample. Due to concern for contamination, 
we extracted DNA from sterile water passed through the bronchoscope prior to utilization; 
the reagents; blank swabs; and sterile water. Sequences detected in control samples clustered 
into 15 OTUs that constituted >80% of total sequence reads detected in negative controls 
(Supplemental Table 1). These OTUs were excluded from all subsequent analysis, and 
represented less than 1.5% abundance in participant samples.
Sequence Analysis
Rarefaction curves describing the number and proportionality of OTUs observed as a 
function of sampling effort were generated using alpha_rarefaction.py in QIIME (1.9.1)17. 
Random sub-sampling to the smallest sample size (3935) was performed to address concerns 
of different sequencing depths across samples affecting the rarefaction curves. Shannon 
diversity and Chao 1 richness indices were calculated from the sub-sampled OTU abundance 
data using QIIME.
The align_seqs.py and make_phylogeny.py commands in QIIME were used to align OTU 
consensus sequences18 and construct a taxonomic tree19. The weighted UniFrac and Bray-
Curtis distances were calculated between participants and sample types for variation analysis 
using the beta diversity.py command in QIIME. Both methods are qualitative measures of 
community dissimilarity, however weighted UniFrac incorporates phylogenetic relatedness 
between OTUs. Principal coordinate analysis (PCoA), which employs an eigenvector-based 
approach, was performed with the QIIME suite to represent the multidimensional data of 
OTU abundance in three dimensions. OTU frequencies were compared across sample types 
and other groups at multiple taxonomic levels using the group_significance.py command 
from QIIME using Student’s t-test. The conservative Bonferroni method of multiple testing 
correction was followed, with each p-value being multiplied by the number of OTU/taxa 
tested.
RESULTS
Thirty-six participants were approached and consented to participate in this study between 
January 2015 and March 2016. One participant was also enrolled in the NIH funded 
observational Early Cystic Fibrosis study. Because the Early Cystic Fibrosis study is an 
observational study, we determined that participating would not influence our results. 
Sequences were successfully measured from all 72 samples.
The 36 participants included in the study consisted of 18 males (50%); had a median age of 
3.3 years (interquartile range 1.3–5.2 years) (Table 1). The most common reason for 
bronchoscopy was chronic cough (61% of participants) followed by noisy breathing (14%) 
(Table 2). The most common underlying diagnosis was recurrent bronchitis/pneumonia 
(67%) followed by asthma (61%) and gastroesophageal reflux (22%) (Table 3). Of the 36 
samples, 24 contained pooled BALF from 2–3 different lobes, while 12 samples were 
obtained from a single lobe. These 12 samples were obtained mainly from the middle (n=6) 
and lower lung lobes (n=5). One sample was obtained from the left upper lobe; none were 
obtained from the right upper lobe. All pooled samples contained fluid from the middle 
and/or lower lobes. Four pooled samples contained fluid from the right upper lobe as well as 
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the middle or lower lobe. Four participants were on antibiotics at the time of bronchoscopy. 
Three of the four participants had positive BALF cultures despite this antibiotic use. The 
other participants denied antibiotic use for in the two weeks prior to the bronchoscopy. 
Rarefaction plots (supplemental Figure 1) revealed that Shannon diversity for all samples 
had stabilized by our chosen cutoff of 3935 reads, indicating all samples had sufficient 
sequencing depth to capture the diversity of the samples.
Differences between NP swabs and BALF
Chao1 richness (a qualitative lower-bounds of OTU richness) and Shannon diversity indices 
(a quantitative measure of OTU abundance and evenness) revealed that BALF samples are 
significantly richer (p = 0.001; nonparametric t-test) and more diverse (p = 0.001; 
nonparametric t-test) than NP swabs (Figure 1). Using principal coordinate analysis (PCoA) 
of the weighted Unifrac, distinct clustering patterns were present between the two sampling 
methods (Figure 2) with the top 3 axes accounting for 68.5% of the variation in samples. 
Monte Carlo permutation testing (n = 999) confirmed that the distance between BALF and 
NP samples was larger than the distance between BALF samples (adjusted p = 0.003) and 
the distance between NP samples (adjusted p = 0.003).
While overall differences were observed between NP and BALF samples, our primary goal 
was to determine if the NP and BALF samples were similar between each individual. During 
analysis, it appeared that within each individual, several OTUs were conserved across BALF 
and NP samples. To formally study this effect, we compared the dissimilarity between the 
microbial communities within individual subjects (intrasubject) to the dissimilarity across 
subjects (intersubject). For this test, we chose the Bray-Curtis distance metric to study the 
conservation of specific OTUs. Compared to NP (p = 0.02; t-test) and BALF samples (p = 
0.001; t-test) obtained from other individuals, an individual’s NP sample more closely 
resembled their own BALF sample (Figure 3). The Bray-Curtis distance metric (utilized 
above) factors in the relative abundance of bacteria present in a sample. To determine if the 
presence or absence of bacteria differed between NP and BALF samples, we utilized 
Sorensen similarity calculations. Compared to unpaired NP/BALF samples, paired NP/
BALF samples are more similar (p = 0.0006).
When adjusting for possible confounders such as age and method of scope introduction, no 
difference was found between the two sample types based on age or method of scope 
introduction (Figure 4).
Relative Abundance of NP and BALF
Within the 36 NP samples, the dominant phyla detected were Firmicutes (54.7%); 
Actinobacteria (21%); Proteobacteria (20.4%); Bacteroidetes (3.2%); Fusobacteria (0.3%); 
and unclassified (0.4%). The 36 BALF samples were dominated by Firmicutes (48.6%); 
Bacteroidetes (29.5%); Proteobacteria (14.8%); Fusobacteria (2.9%); Actinobacteria (2.2%); 
Tenericutes (1.4%); and unclassified (0.6%). Sequences were annotated to the lowest 
available taxonomic classification.
The most abundant genera in the NP microbiota were Streptococcus (37.3%); 
Staphylococcus (14.6%); Haemophilus (10.1%); Corynebacteriaceae unknown genus 
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(11.5%); Moraxella (7.7%); Corynebacterium (5.3%); Propionibacterium (3.9%); 
Porphyromonas (1.4%); Neisseria (1.4%); Veillonella (1.3%); and Neisseriaceae unknown 
genus (1%). In the BALF, Streptococcus was also the most abundant genera (36.1%); 
followed by Neisseria (10.3%); Prevotella 7 (9.4%); Alloprevotella (8.5%); Porphyromonas 
(7.3%); Staphylococcus (4%); Veillonella (3.8%); Prevotella (2.9%); Fusobacterium (2.5%); 
Haemophilus (1.7%); Propionibacterium (1.5%); Granulicatella (1.4%); Mycoplasma 
(1.4%); and Gemella (1%). All other classified OTUs belong to genera compromising less 
than 1% of the total abundance.
To further explore the differences between upper and lower airway microbiota, we compared 
the relative abundance of BALF and NP samples using the Kruskal-Wallis nonparametric 
test and found significant differences at the phyla level. While BALF samples had more 
Bacteroidetes (29.5% vs. 3.2%; adjusted p = 1.2 × 10−9), NP samples had more 
Actinobacteria (2.2% vs. 21%; adjusted p = 1.4 × 10−6) (Figure 5).
Further classification of the NP samples revealed higher abundance of bacteria within two 
genera of the Family Corynebacteriaceae. These include an unclassified genera (NP 11.5% 
vs. 0.04%; adjusted p = 8.9 × 10−5) (Figure 6) and Corynebacterium (NP 5.3% vs. 0.06%; 
adjusted p = 0.039). In addition, NP samples had a higher abundance of bacteria from the 
genus Staphylococcus (NP 14.6% vs. 4%; adjusted p = 0.002). In contrast, NP samples 
contained lower abundance of three genera within Family Prevotellaceae including: 
Prevotella 7 (NP 0.8% vs. 9.4%; adjusted p = 1.2 × 10−5), Prevotella (NP 0.2% vs. 2.9%; 
adjusted p = 5.6 × 10−7), and Alloprevotella (NP 0.6% vs. 8.5%; adjusted p = 3.4 × 10−6). At 
the genera level, Moraxella (BAL 0.2% vs. NP 7.7%, adjusted p = 0.003) and Haemophilus 
(BAL 1.7% vs. NP 10.1%, adjusted p = 1) abundance were higher in NP samples, while 
Streptococcus abundance was similar in both BALF and NP samples (NP 37.3% vs. 36.1%; 
adjusted p = 0.8).
To determine if organisms detected in clinically obtained BALF cultures were also present in 
the BALF microbiota, we compared culture results with each participant’s corresponding 
BALF 16S rRNA sequencing results. BALF cultures were clinically performed in 34 of 36 
samples. 22 of 34 samples (65%) were culture positive to at least one organism. In all 22 
culture positive participants, the organisms present in their BALF culture were also present 
in the participant’s corresponding BALF microbiota. A correlation between the presence of 
bacteria in culture and the abundance of bacteria in the BALF microbiota was not detected.
DISCUSSION
When comparing the microbiota between BALF and NP samples in children undergoing 
clinically indicated bronchoscopy, NP swabs reflected BALF within an individual. However, 
when samples were grouped based on type (NP vs. BALF), differences were noted. These 
differences were likely due to averaging the relative abundance of multiple samples and 
suggests that caution should be made when making conclusions utilizing this method. 
Because intra-sample similarity was greater than inter-sample similarity, it is likely that 
differences will be detected between individuals regardless of the type of sampling method 
utilized.
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Describing a ‘normal’ lung microbiota in children is difficult due to our inability to perform 
bronchoscopy on healthy children. Previous studies have utilized upper airway samples as a 
surrogate of lower airway samples. However, adult studies comparing upper and lower 
airway microbiota demonstrate differences between the two1,2,20, suggesting that upper 
airway samples do not represent the lower airway microbiota. Due to ethical concerns 
surrounding the collection of lower airway samples in healthy ‘normal’ children, samples 
were collected from children undergoing clinically indicated outpatient bronchoscopy (Table 
2). While similar bacteria were found in both the upper and lower airway, other bacteria 
were only reported in one location. One such bacteria, Prevotella, was significantly more 
abundant in BALF than in NP samples. Similar findings have been reported in adult 
microbiota studies that examined oral swabs, BALF and gastric fluid2, suggesting that other 
locations (mouth, GI tract) may contribute to the microbial make-up of the lower airway. 
Furthermore, in children with cystic fibrosis, the relative abundance of Pseudomonas and 
Staphylococcus was higher in the lower airway compared to the upper airway, further 
suggesting that NP samples are not always good surrogates for the lower airway 
microbiota3,21. It was recently demonstrated that within young children with airway disease, 
combining OP and NP samples reflected BALF samples better than utilizing only OP or NP 
samples alone.5 It may be possible that if we had analyzed OP swabs as well, we would have 
seen Prevotella in higher quantities in the upper airway. Future studies have been planned to 
utilize both methods of upper airway sampling in our pediatric studies.
In our pediatric participants the most common genera in both BALF and NP samples was 
Streptococcus. Interestingly, the relative abundance of Streptococcus was similar in both 
locations. Bronchoscope contamination or carryover from the upper airway can occur and 
influence BALF samples. While Streptococcus abundance was similar between the two 
types of samples, there was a lack of similar abundance of other OTUs. Therefore, we 
believe upper airway contamination of lower airway samples did not occur in our 
population. To determine if the route of bronchoscope entry influenced the BALF results, we 
compared the two routes of performing bronchoscopy (through a laryngeal mask airway and 
trans-nasally) finding no difference in OTU richness (p = 0.41; nonparametric t-test) or 
community diversity (p = 0.17; non-parametric t-test) between the routes of bronchoscope 
introduction. Principal coordinate analysis of weighted Unifrac did not show distinct clusters 
for route of entry, and Monte Carlo permutation testing did not find a significant difference 
in the distance between laryngeal mask BALF and trans-nasal BALF samples as compared 
to the distance within laryngeal mask samples (adjusted p = 0.52 ) or trans-nasal samples 
(adjusted p = 0.21).
A limitation of this study may be an insufficient number of samples to measure significant 
differences in community structure, and differences based on age. Because power 
calculations for microbiota analysis have not been standardized, determining the number 
needed to reach significance can be challenging.. We divided samples into quartiles based on 
age in an attempt to examine if age impacted richness, diversity and/or changes in relative 
abundance but we did not find significant differences. A larger sample size would help 
further define and verify individual communities of bacteria across the various age groups 
thereby determining if borderline significant data is actually significant. While we attempted 
to standardize our sampling methods as much as possible, the procedures were clinically 
Kloepfer et al. Page 7
Pediatr Pulmonol. Author manuscript; available in PMC 2019 May 30.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
indicated; therefore, the route used to introduce the bronchoscope (laryngeal mask airway 
(LMA) or nasal) and which lung lobes to sample were selected by the performing physician. 
However, we collected the NP sample prior to bronchoscopy to limit possible contamination 
of lower airway bacteria on the upper airway during scope removal. Also, during analysis we 
compared BALF samples obtained via laryngeal mask airway (LMA) versus nasal entry and 
did not find a difference, suggesting that the route of entry did not impact sample analysis. 
Because we could not control which lobe(s) were sampled, BALF may only represent the 
area(s) of the lung sampled and not the entire lung. Our finding that diversity is greater in 
BALF than NP samples was previously reported in children with cystic fibrosis3. It is 
possible that the bacterial load differs between these two sampling methods thereby resulting 
in differences in diversity. Due to low sample volume, we were unable to perform qPCR on 
our samples to determine overall bacterial load. Future studies will focus on measuring 
bacterial load. Contaminating DNA can be a challenge in samples with low microbial 
biomass22 therefore we extracted DNA from controls and excluded OTUs detected in our 
negative controls (supplemental Table 1) to prevent reporting bacterial contaminants.
In summary, we have performed a comparison of NP swabs and BALF in a pediatric 
population undergoing clinically indicated bronchoscopies. We report that the pediatric NP 
airway microbiota is similar to BALF samples for an individual but often have significantly 
different relative abundance of bacteria. Studies utilizing NP samples as surrogates for the 
lower airway, should be interpreted with caution.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Mean diversity between BALF and NP samples utilizing Chao1 Richness index p=0.001 
(A), and Shannon Diversity p=0.001 (B).
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Figure 2: 
Weighted Unifrac Plot presents the multidimensional data of OTU abundance in three 
dimensions. It visually demonstrates that distinct clustering patterns were present between 
the two sampling methods. Red dots = BALF. Blue dots=NP swabs.
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Figure 3: 
Comparison of similarity between sample types. Microbiota detected in NP samples were 
more similar to their corresponding BALF (intra-subject comparison) compared to 
microbiota in BALF from other children (inter-subject comparison) (p=0.001). Intra-subject 
NP and BALF microbiota was also more similar than NP samples between children 
(p=0.02). Bray-Curtis dissimilarity is bounded between 0 and 1, so two samples with a 
distance of 1 would share no OTUs, where at 0 the samples would contain the same OTUs in 
the same proportionality.
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Figure 4: 
Weighted Unifrac Plot visually demonstrates that distinct clustering patterns were present 
between the three methods of bronchoscopy. Orange dots = nasal bronchoscopy. Red dots = 
bronchoscopy via laryngeal mask airway (LMA). Blue dots= NP swabs.
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Figure 5: 
BALF versus NP samples reported at phyla level. Purple= Proteobacteria; Orange-
Firmicutes; Blue=Bacteroidetes; and red= Actinobacteria.
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Figure 6: 
Bacterial Abundance of 15 most common OTUs. *adjusted p<0.001; **adjusted p<0.01; 
†adjusted p<0.05.
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Table 1
Demographics
Gender 50% Male (n=18)
Median Age (IQR) 3.3 years (3 months – 18.3 years)
Race Black/African American: 1
White/Caucasian: 29
Other: 3
No response: 3
Ethnicity Hispanic/Latino: 3
Non-Hispanic/Latino: 24
No response: 9
IQR: Interquartile range
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Table 2
Reason for Bronchoscopy.
Reason for Bronchoscopy Number of Participants with Diagnosis (n=36)
Chronic cough 22 (61%)
Noisy breathing 5 (14%)
Recurrent Wheeze 4 (11%)
Recurrent Pneumonia 4 (11%)
Chronic shortness of breath with recent diagnosis of systemic scleroderma 1 (3%)
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Table 3
Underlying Diagnoses prior to Bronchoscopy. Because some participants had more than one diagnosis, there 
are more diagnoses than participants.
Underlying Diagnosis Number of Participants with Diagnosis (n=36)
Recurrent Bronchitis/Pneumonia 24 (67%)
Asthma 22 (61%)
Gastroesophageal Reflux 8 (22%)
Cystic Fibrosis 3 (8%)
CFTR related metabolic disorder 1 (3%)
Bronchopulmonary Dysplasia 1 (3%)
Obstructive Sleep Apnea 1 (3%)
Seizures 1 (3%)
Scleroderma 1 (3%)
CFTR = Cystic Fibrosis Transmembrane Regulator protein.
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